13F Insight
DOSSIER · 13F Holders · Q3 2026
APUS

APIMEDS PHARMACEUTICALS US I

2 institutions still hold APIMEDS PHARMACEUTICALS US I as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 03771D201·2 13F holders·last filed Sep 30, 2026
Market cap
—
13F value held
$32K
visible holders
Holders
2
filers reporting
Concentration
99.98%
UBS Group AG #1
top holder share
AI Holders Summary · Q3 2026

2 institutions reported APUS in Q3 2026. UBS Group AG leads at 100.0% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
UBS Group AG
CIK 0001610520
$32K6K0.00%Q3 202602
CITIGROUP INC
CIK 0000831001
$510.00%Q3 2026
Insiders at APIMEDS PHARMACEUTICALS US I
Koo Jakap →Yoon Hankil →Weintraub Bennett →Kogan Elona →O'Donnell Carol A →Kim Christopher →Emerson Erik C. →Inscobee Inc. →